CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial Fibrillation

Background: Recent studies have shown an association between CHA2DS2-VASc (congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, stroke or transient ischemic attack (TIA), vascular disease, age 65 to 74 years, sex category) score and outcome of acute myocardial infarction, strok...

Full description

Bibliographic Details
Main Authors: Bo-Yuan Wang, Fei-Yi Lin, Min-Sho Ku, Yu-Hsun Wang, Kun-Yu Lee, Sai-Wai Ho
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/18/4093
_version_ 1797518724160290816
author Bo-Yuan Wang
Fei-Yi Lin
Min-Sho Ku
Yu-Hsun Wang
Kun-Yu Lee
Sai-Wai Ho
author_facet Bo-Yuan Wang
Fei-Yi Lin
Min-Sho Ku
Yu-Hsun Wang
Kun-Yu Lee
Sai-Wai Ho
author_sort Bo-Yuan Wang
collection DOAJ
description Background: Recent studies have shown an association between CHA2DS2-VASc (congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, stroke or transient ischemic attack (TIA), vascular disease, age 65 to 74 years, sex category) score and outcome of acute myocardial infarction, stroke, and chest pain. As pneumonia can affect the cardiovascular system, this study aimed to investigate the performance of the CHA2DS2-VASc score for major adverse cardiovascular events (MACEs) risk stratification in patients with pneumonia. Methods: A retrospective population-based cohort study including 61,843 patients with pneumonia. These patients were divided into two cohorts that were stratified based on the presence or absence of underlying atrial fibrillation (AF). We calculated the CHA2DS2-VASc score and incidence density rates of MACEs in each cohort. Cox regression was conducted to calculate hazard ratio of MACEs in pneumonia patients. The diagnostic performance of CHA2DS2-VASc with regard to MACEs was tested using the receiver operator characteristic curve. Results: Pneumonia patients with higher CHA2DS2-VASc score were more likely develop MACEs in both the AF and non-AF groups. In the AF group, the areas under the curve (AUC), sensitivity, and specificity were 0.824 (0.7773–0.8708), 0.7, and 0.84 respectively. In the non-AF group, the AUC, sensitivity, and specificity were 0.8185 (0.8152–0.8217), 0.75, and 0.83 respectively. Conclusions: The CHA2DS2-VASc score showed good performance in the prediction of MACE in patients with pneumonia.
first_indexed 2024-03-10T07:33:40Z
format Article
id doaj.art-3a3f2adfcaaf494da7c987863e8c3c57
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T07:33:40Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-3a3f2adfcaaf494da7c987863e8c3c572023-11-22T13:39:20ZengMDPI AGJournal of Clinical Medicine2077-03832021-09-011018409310.3390/jcm10184093CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial FibrillationBo-Yuan Wang0Fei-Yi Lin1Min-Sho Ku2Yu-Hsun Wang3Kun-Yu Lee4Sai-Wai Ho5Department of Emergency Medicine, Chung Shan Medical University Hospital, Taichung 402, TaiwanDepartment of Nursing, Chung Shan Medical University Hospital, Taichung 402, TaiwanDivision of Allergy, Asthma and Rheumatology, Department of Pediatrics, Chung Shan Medical University Hospital, Taichung 402, TaiwanDepartment of Medical Research, Chung Shan Medical University Hospital, Taichung 402, TaiwanDepartment of Emergency Medicine, Chung Shan Medical University Hospital, Taichung 402, TaiwanDepartment of Emergency Medicine, Chung Shan Medical University Hospital, Taichung 402, TaiwanBackground: Recent studies have shown an association between CHA2DS2-VASc (congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, stroke or transient ischemic attack (TIA), vascular disease, age 65 to 74 years, sex category) score and outcome of acute myocardial infarction, stroke, and chest pain. As pneumonia can affect the cardiovascular system, this study aimed to investigate the performance of the CHA2DS2-VASc score for major adverse cardiovascular events (MACEs) risk stratification in patients with pneumonia. Methods: A retrospective population-based cohort study including 61,843 patients with pneumonia. These patients were divided into two cohorts that were stratified based on the presence or absence of underlying atrial fibrillation (AF). We calculated the CHA2DS2-VASc score and incidence density rates of MACEs in each cohort. Cox regression was conducted to calculate hazard ratio of MACEs in pneumonia patients. The diagnostic performance of CHA2DS2-VASc with regard to MACEs was tested using the receiver operator characteristic curve. Results: Pneumonia patients with higher CHA2DS2-VASc score were more likely develop MACEs in both the AF and non-AF groups. In the AF group, the areas under the curve (AUC), sensitivity, and specificity were 0.824 (0.7773–0.8708), 0.7, and 0.84 respectively. In the non-AF group, the AUC, sensitivity, and specificity were 0.8185 (0.8152–0.8217), 0.75, and 0.83 respectively. Conclusions: The CHA2DS2-VASc score showed good performance in the prediction of MACE in patients with pneumonia.https://www.mdpi.com/2077-0383/10/18/4093CHA2DS2-VASc scoremajor adverse cardiovascular eventspneumonia
spellingShingle Bo-Yuan Wang
Fei-Yi Lin
Min-Sho Ku
Yu-Hsun Wang
Kun-Yu Lee
Sai-Wai Ho
CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial Fibrillation
Journal of Clinical Medicine
CHA2DS2-VASc score
major adverse cardiovascular events
pneumonia
title CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial Fibrillation
title_full CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial Fibrillation
title_fullStr CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial Fibrillation
title_full_unstemmed CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial Fibrillation
title_short CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial Fibrillation
title_sort cha2ds2 vasc score for major adverse cardiovascular events stratification in patients with pneumonia with and without atrial fibrillation
topic CHA2DS2-VASc score
major adverse cardiovascular events
pneumonia
url https://www.mdpi.com/2077-0383/10/18/4093
work_keys_str_mv AT boyuanwang cha2ds2vascscoreformajoradversecardiovasculareventsstratificationinpatientswithpneumoniawithandwithoutatrialfibrillation
AT feiyilin cha2ds2vascscoreformajoradversecardiovasculareventsstratificationinpatientswithpneumoniawithandwithoutatrialfibrillation
AT minshoku cha2ds2vascscoreformajoradversecardiovasculareventsstratificationinpatientswithpneumoniawithandwithoutatrialfibrillation
AT yuhsunwang cha2ds2vascscoreformajoradversecardiovasculareventsstratificationinpatientswithpneumoniawithandwithoutatrialfibrillation
AT kunyulee cha2ds2vascscoreformajoradversecardiovasculareventsstratificationinpatientswithpneumoniawithandwithoutatrialfibrillation
AT saiwaiho cha2ds2vascscoreformajoradversecardiovasculareventsstratificationinpatientswithpneumoniawithandwithoutatrialfibrillation